NeuroPace to Participate in Two Healthcare Conferences in May
NeuroPace (Nasdaq: NPCE), a medical device company specializing in epilepsy treatment, announced its participation in two healthcare conferences in May 2024. The company will join the Wells Fargo 2024 West Coast MedTech Tour on May 28 at 2:30pm PT in Menlo Park, CA, featuring a fireside chat with investors.
Additionally, NeuroPace will present at the Leerink Partners Healthcare Crossroads Conference from May 28-30 in Austin, TX. CEO Joel Becker will deliver a corporate presentation on May 30 at 8:00am CT, and the company will engage in one-on-one meetings with investors. The presentation will be available via live webcast and replay on NeuroPace’s Investor website.
- NeuroPace's participation in prominent healthcare conferences could increase investor interest and visibility.
- CEO Joel Becker's presentation and one-on-one meetings at the Leerink Partners Healthcare Crossroads Conference may attract potential investors.
- Availability of the webcast and replay ensures broader access to the presentation, potentially boosting transparency and investor confidence.
- No immediate financial data or clinical results were disclosed in the announcement.
- The outcomes of the conferences are uncertain and may not lead to direct investment or business growth.
- The company's focus on participation in conferences may not address underlying financial or clinical challenges.
MOUNTAIN VIEW, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will participate in two healthcare conferences in May. NeuroPace management will participate in the Wells Fargo 2024 West Coast MedTech Tour at 2:30pm PT on Tuesday, May 28 in Menlo Park, CA. The format will be a fireside chat with a group of investors.
NeuroPace will also present at the Leerink Partners Healthcare Crossroads Conference, which takes place May 28-30, in Austin, TX. Joel Becker, NeuroPace’s Chief Executive Officer, will provide a corporate presentation on Thursday, May 30 at 8:00am CT, and management will participate in one-on-one meetings with investors during the conference. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available on the Events section of NeuroPace’s Investor website at https://investors.neuropace.com/news-and-events/events.
About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.
Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com
FAQ
When will NeuroPace participate in the Wells Fargo 2024 West Coast MedTech Tour?
What is NeuroPace's stock symbol?
Where can I watch the live webcast of NeuroPace’s presentation at the Leerink Partners Healthcare Crossroads Conference?
Who will present on behalf of NeuroPace at the Leerink Partners Healthcare Crossroads Conference?
What type of event will NeuroPace participate in during the Wells Fargo 2024 West Coast MedTech Tour?
